Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia

被引:139
作者
Migliazza, A
Bosch, F
Komatsu, H
Cayanis, E
Martinotti, S
Toniato, E
Guccione, E
Qu, XY
Chien, M
Murty, VVV
Gaidano, G
Inghirami, G
Zhang, PS
Fischer, S
Kalachikov, SM
Russo, J
Edelman, I
Efstratiadis, A
Dalla-Favera, R
机构
[1] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA
[4] Columbia Univ, Genome Ctr, New York, NY 10032 USA
[5] A Avogadro Univ Eastern Piedmont, Dept Med Sci, Novara, Italy
[6] NYU, Med Ctr, New York, NY 10016 USA
关键词
D O I
10.1182/blood.V97.7.2098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deletions of the 13q14 chromosome region are associated with B-cell chronic lymphocytic leukemia (B-CLL) and several other types of cancer, suggesting the presence of a tumor suppressor gene. In previous studies the minimal region of deletion (MDR) was mapped to a less than 300-kilobase (kb) interval bordered by the markers 173a12-82 and 138G4/1.3R. For the identification of the putative tumor suppressor gene, the entire MDR (approximately 347 kb) has been sequenced, and transcribed regions have been identified by exon trapping, EST-based full-length complementary DNA cloning, database homology searches, and computer-assisted gene prediction analyses. The MDR contains 2 pseudogenes and 3 transcribed genes: CAR, encoding a putative RING-finger containing protein; 1B4/Leu2, generating noncoding transcripts; and EST70/Leu1, probably representing another noncoding gene (longest open reading frame of 78 codons). These genes have been sequenced in 20 B-CLL cases with 13q14 hemizygous deletion, and no mutations were found. Moreover, no somatic variants were found in the entire MDR analyzed for nucleotide substitutions by a combination of direct sequencing and fluorescence-assisted mismatch analysis in 5 B-CLL cases displaying 13q14-monoallelic deletion. The nondeleted allele of the CAR and EST70/Leu1 genes was expressed in B-CLL specimens, including those with monoallelic loss, whereas no expression of 1B4/Leu2 was detectable in B-CLL, regardless of the 13q14 status. These results indicate that allelic loss and mutation of a gene within the MDR is an unlikely pathogenetic mechanism for B-CLL. However, haplo-insufficiency of one of the identified genes may contribute to tumorigenesis.
引用
收藏
页码:2098 / 2104
页数:7
相关论文
共 59 条
  • [1] ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
  • [2] Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
    Avet-Loiseau, H
    Li, JY
    Morineau, N
    Facon, T
    Brigaudeau, C
    Harousseau, JL
    Grosbois, B
    Bataille, R
    [J]. BLOOD, 1999, 94 (08) : 2583 - 2589
  • [3] Bentley DR, 2000, MED RES REV, V20, P189, DOI 10.1002/(SICI)1098-1128(200005)20:3<189::AID-MED2>3.0.CO
  • [4] 2-#
  • [5] Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3
    BouygeMoreau, I
    Rondeau, G
    AvetLoiseau, H
    Andre, MT
    Bezieau, S
    Cherel, M
    Saleun, S
    Cadoret, E
    Shaikh, T
    DeAngelis, MM
    Arcot, S
    Batzer, M
    Moisan, JP
    Devilder, MC
    [J]. GENOMICS, 1997, 46 (02) : 183 - 190
  • [6] Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia
    Bullrich, F
    Veronese, ML
    Kitada, S
    Jurlander, J
    Caligiuri, MA
    Reed, JC
    Croce, CM
    [J]. BLOOD, 1996, 88 (08) : 3109 - 3115
  • [7] Bullrich F, 1999, CANCER RES, V59, P24
  • [8] Prediction of complete gene structures in human genomic DNA
    Burge, C
    Karlin, S
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 268 (01) : 78 - 94
  • [9] B-cell chronic lymphocytic leukemia: A bird of a different feather
    Caligaris-Cappio, F
    Hamblin, TJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 399 - 408
  • [10] National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
    Cheson, BD
    Bennett, JM
    Grever, M
    Kay, N
    Keating, MJ
    OBrien, S
    Rai, KR
    [J]. BLOOD, 1996, 87 (12) : 4990 - 4997